OTX2 (Orthodenticle Homeobox 2) is the most frequent target of focal gain in the medulloblastoma genome [3], [9], and this event occurs almost exclusively in non-Shh/non-Wnt medulloblastomas [4], [9]. This evidence concerns the gene SHH and medulloblastoma.